Can MannKind Shares Double Again on FDA Approval? (Updated)

Can MannKind Shares Double Again on FDA Approval? (Updated)

MannKind announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 13 to one to recommend that Afrezza be granted FDA marketing approval to improve glycemic control in adults with type 1 diabetes. This same FDA …

10
Like
Save

Comments

Write a comment

*